These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3278857)

  • 1. Blood pressure and uremic cardiomyopathy.
    Rambausek M; Kollmar S; Mall G; Ritz E
    Contrib Nephrol; 1988; 60():230-5. PubMed ID: 3278857
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenetic aspects of uremic cardiomyopathy.
    Coratelli P; Buongiorno E; Petrarulo F; Corciulo R; Giannattasio M; Passavanti G; Antonelli G
    Miner Electrolyte Metab; 1989; 15(4):246-53. PubMed ID: 2761492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats.
    Suassuna PGA; Cherem PM; de Castro BB; Maquigussa E; Cenedeze MA; Lovisi JCM; Custódio MR; Sanders-Pinheiro H; de Paula RB
    Exp Biol Med (Maywood); 2020 Jan; 245(1):66-78. PubMed ID: 31847589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose growth hormone is cardioprotective in uremia.
    Rabkin R; Awwad I; Chen Y; Ashley EA; Sun D; Sood S; Clusin W; Heidenreich P; Piecha G; Gross ML
    J Am Soc Nephrol; 2008 Sep; 19(9):1774-83. PubMed ID: 18650479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.
    Gross ML; Ritz E
    Semin Dial; 2008; 21(4):308-18. PubMed ID: 18627569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin.
    Semple DJ; Bhandari S; Seymour AM
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1275-86. PubMed ID: 22914780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cardiac contractility in acute uremia: interrelationships with hypertension.
    Nivatpumin T; Yipintsoi T; Penpargkul S; Scheuer J
    Am J Physiol; 1975 Aug; 229(2):501-5. PubMed ID: 240283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats.
    Breborowicz A; Połubinska A; Wu G; Tam P; Oreopoulos DG
    Blood Purif; 2006; 24(3):274-81. PubMed ID: 16465047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Target blood pressure for uremic patients on intermittent hemodialysis].
    Lusenti T
    G Ital Nefrol; 2008; 25(6):612. PubMed ID: 19048552
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uremic rat model: experience with young rats.
    Kleinknecht C; Laouari D; Burtin M
    Contrib Nephrol; 1988; 60():27-38. PubMed ID: 3278859
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac function in experimental uremia.
    Kreusser W; Mann J; Rambausek M; Klooker P; Mehls O; Ritz E
    Kidney Int Suppl; 1983 Nov; 15():S83-8. PubMed ID: 6368951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermyoinositolemic polyneuropathy in rats. A possible mechanism for uremic polyneuropathy.
    DeJesus PV; Clements RS; Winegrad AI
    J Neurol Sci; 1974 Mar; 21(3):237-49. PubMed ID: 4361661
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetically altered rodent models in the endothelin-related genes].
    Emoto N; Yokoyama M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():311-5. PubMed ID: 16897870
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats.
    Odenwald T; Nakagawa K; Hadtstein C; Roesch F; Gohlke P; Ritz E; Schaefer F; Schmitt CP
    J Am Soc Nephrol; 2006 Mar; 17(3):655-62. PubMed ID: 16421225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastolic dysfunction and abnormality of the Na+/Ca2+ exchanger in single uremic cardiac myocytes.
    McMahon AC; Naqvi RU; Hurst MJ; Raine AE; MacLeod KT
    Kidney Int; 2006 Mar; 69(5):846-51. PubMed ID: 16518344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.
    Kennedy DJ; Vetteth S; Periyasamy SM; Kanj M; Fedorova L; Khouri S; Kahaleh MB; Xie Z; Malhotra D; Kolodkin NI; Lakatta EG; Fedorova OV; Bagrov AY; Shapiro JI
    Hypertension; 2006 Mar; 47(3):488-95. PubMed ID: 16446397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.